Surfaxin News
Most Popular Surfaxin Story
FDA rejects Discovery Labs' Surfaxin
Shares of Discovery Laboratories plunged today as the FDA announced that it wouldn't approve the company's drug Surfaxin for treatment of respiratory illness in infants. The agency's primary question Read more...
Latest Headlines
- October 15, 2010
- February 16, 2010
- September 30, 2009
- September 11, 2009
- July 1, 2009
- April 20, 2009
- May 27, 2008
- May 2, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
